A New Chapter: UNITED II
Building on the success of the UNITED study, we are excited to launch UNITED II. This next phase will further explore and validate the prognostic and predictive value of the tumor-stroma ratio (TSR), bringing us one step closer to clinical implementation. With new insights and collaborations, UNITED II marks an important step in translating research into practice—improving personalized treatment for cancer patients. Stay tuned for updates as we embark on this new chapter!
